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E-mail address: zhouhj_zhouhj@yahoo.com (H.-J. ZDihydroartemisinin (DHA), an active metabolite of artemisinin derivatives, is the most remarkable
anti-malarial drug and has little toxicity to humans. Recent studies have shown that DHA effectively
inhibits the growth of cancer cells. In the present study, we intended to elucidate the mechanisms
underlying the inhibition of growth of iron-loaded human myeloid leukemia K562 cells by DHA.
Mitochondria are important regulators of both autophagy and apoptosis, and one of the triggers
for mitochondrial dysfunction is the generation of reactive oxygen species (ROS). We found that
the DHA-induced autophagy of leukemia K562 cells, whose intracellular organelles are primarily
mitochondria, was ROS dependent. The autophagy of these cells was followed by LC3-II protein
expression and caspase-3 activation. In addition, we demonstrated that inhibition of the prolifera-
tion of leukemia K562 cells by DHA is also dependent upon iron. This inhibition includes the down-
regulation of TfR expression and the induction of K562 cell growth arrest in the G2/M phase.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction by the delivery to and subsequent degradation in lysosomesArtemisinin, the active component of the Chinese plant qinghao
(Artemisia annua L.), is a remarkable and novel anti-malarial drug
with little toxicity [1]. It contains an endoperoxide bridge that
reacts with ferrous iron to generate free radicals, such as reactive
oxygen species (ROS), which leads to macromolecular damage
and cell death. Dihydroartemisinin (DHA), its most active deriva-
tive [2], has been recently reported to possess a preferentially cyto-
toxic effect on cancer cells [3,4]. It has been reported that DHA kills
cancer cells via an iron-mediated mechanism [5], and this was fur-
ther conﬁrmed by a later experiment, by the same research group,
on human breast cancer cells [6]. More recently, Lai et al. reported
that artemisinin that is tagged with holotransferrin is more effec-
tive than artemisinin alone in killing cancer cells [7]. Because the
endoperoxide bridge of dihydroartemisinin is essential for its cyto-
toxicity, the effects of its reaction with iron and the resulting prod-
uct, ROS, deserve more investigation.
Autophagy is a non-apoptotic cell death mechanisms character-
ized by the engulfment of the cytoplasm and organelles by
double-membrane bound structures, autophagosomes, followedal Societies. Published by Elsevier
hosphate buffer saline; TfR,
TT, 3-(4,5-dimethylthiazol-2-
ange; EB, ethidium bromide;
hou).[8–10]. Autophagy has been reported to play a crucial role in many
diseases, such as cancer, infectious diseases, and neurodegenera-
tive disorders [11–14]. During autophagy, microtubule-associated
protein 1 light chain 3 (LC3) is cleaved at its C-terminal arginine
residue to form LC3-I. LC3-I is easily activated, conjugated to phos-
phatidylethanolamine, and subsequently bound to the membrane
to form LC3-II. LC3-II is localized in the autophagosome and has
been utilized as an autophagosome marker.
The role of autophagy in tumor progression is complex. In some
systems, the induction of autophagy has been shown to contribute
to or enhance the apoptotic response [15].
Mitochondria are important regulators of both autophagy and
apoptosis, and one of the triggers for mitochondrial dysfunction
are the ROS. ROS induce damage to the membrane, DNA, protein,
and organelles. Therefore, mechanisms regulating the function
and quantity of mitochondria are essential for eukaryotic cell func-
tion. Autophagy contributes to the maintenance of mitochondria
by their clearance [16], and this process is mediated by a selective
type of autophagy termed mitophagy [17–19]. Recent studies have
also highlighted the important contributions of generated ROS to
this response.
Evidence is also emerging that mitochondria play a key role in
the activation or ampliﬁcation of the caspase cascade. The activa-
tion of a family of intracellular cysteine proteases, called caspases,
is vital to the initiation and execution of apoptosis that is induced
by various stimuli. Of the several different caspases identiﬁed in
mammalian cells, caspase-3 plays a primary role in the proteolyticB.V. Open access under CC BY-NC-ND license.
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apoptosis [20,21].
Iron is fundamental for life because it is a cofactor of enzymes,
such as cytochrome c and ribonucleotide reductase, that are essen-
tial for ATP production and DNA synthesis. The uptake of iron from
transferrin (Tf) is controlled by the expression of its receptor,
transferrin receptor (TfR), which is modulated by intracellular iron
levels [22,23]. Erythroid precursors and malignant cells, especially
leukemia, are highly dependent upon iron to sustain their charac-
teristically high proliferation rates, and the TfR is expressed at
higher levels in these cells [24,25]. This characteristic renders
tumor cells more sensitive to iron depletion, which is well known
to cause cell apoptosis or autophagy [26,27].
In the present study, we intended to elucidate the mechanisms
underlying the autophagy induced by DHA and the inhibition of
growth of iron-loaded human myeloid leukemia K562 cells. We
found that DHA-induced autophagy, in which vacuoles contain
intracellular organelles that are primarily mitochondria, is ROS
dependent. The autophagy is followed by LC3-II protein expression
and caspase-3 activation. We also demonstrated that the inhibition
of leukemia K562 cell proliferation by DHA is also dependent upon
iron, and this inhibition includes the down-regulation of TfR
expression and the induction of K562 cell growth arrest in the
G2/M phase.
2. Experimental procedures
2.1. Reagents
Dihydroartemisinin was kindly provided by Engineer Liuxu
of Guiling Pharmaceutical Co. (Guangxi, China). Holotransferrin
(iron-loaded) was purchased from Sigma (St. Louis, Missouri,
USA). Rabbit anti-Beclin 1 polyclonal antibody, mouse anti-TfR
(3B8 2A1), rabbit anti-Caspase-3 (H-277), and goat anti-actin poly-
clonal antibody (I-19) and all the secondary antisera were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, California,
USA). Rabbit anti-LC3 monoclonal antibody was purchased from
Cell Signaling Technology (Beverly, MA, USA). Acridine orange
(AO), ethidium bromide (EB), and propidium iodide (PI) were ob-
tained from Sigma (St. Louis, MO, USA).
2.2. Cell culture
K562, a chronic myelogenous leukemia line, was obtained
from the Shanghai Institute of Biochemistry and Cell Biology,
Chinese Academy of Sciences (Shanghai, China). Cells were grown
in RPMI1640 standard medium, supplemented with 10% fetal calf
serum and antibiotics (100 IU/ml penicillin and 100 lg/ml strep-
tomycin), in humidiﬁed air at 37 C with 5% CO2. Exponentially
growing cells were used throughout the study.
2.3. Transmission electron microscopy analysis
Cells were ﬁxed overnight in 2.5% glutaraldehyde in 0.2 M phos-
phate buffer before being post-ﬁxed in 1% OsO4 for 45 min. Subse-
quently, the cells were dehydrated in an ethanol series and
embedded in embedding medium. Ultra-thin sections were stained
with uranyl acetate and lead citrate and observed under a Philips-
TECNAI10 transmission electron microscope.
2.4. Growth inhibition assay
The in vitro growth inhibition effect of DHA on leukemia cells
was determined by a modiﬁed microculture tetrazolium (MTT)
assay.2.5. Morphological examination for apoptosis (AO/EB staining)
The apoptotic morphology was studied in K562 cells stained
with a combination of the ﬂuorescent DNA-binding dyes acridine
orange and ethidium bromide (100 lg/ml each in phosphate buffer
saline) [28]. The viable cells display nucleiwith bright green ﬂuores-
cence and homogeneous chromatin, whereas apoptotic cells show
condensed and fragmented chromatin with bright orange ﬂuores-
cence. Necrotic cells display a diffuse orange staining pattern.
After being incubated with DHA for 48 h, K562 cells were
washed twice with PBS and incubated for 3–5 min with AO/EB at
room temperature in the dark. The cells were then observed using
an inverted ﬂuorescence microscope (DMIL, Leica Microsystems,
Wetzlar, Germany) and photographed.
2.6. Flow cytometry analysis
To quantitate intracellular staining of TfR (CD71), mouse mono-
clonal anti-human TfR antibody and FITC conjugated goat anti-
mouse immunoglobulin antiserum (Santa Cruz-2010, Santa Cruz,
California, USA) were used for ﬂow cytometric analysis. An isotype
IgG (Santa Cruz-2855, Santa Cruz, California, USA) was used as a
negative control. Samples were analysed by ﬂow cytometry
(Becton Dickinson, Lincoln Park, NJ, USA). A typical viable cell area
was gated and 1  104 events were counted. The isotype negative
control was used to deﬁne the threshold of the background stain-
ing. All measurements were performed according to manufac-
turer’s instructions.
To quantitate apoptosis, ﬂow cytometric analysis was per-
formed using propidium iodide (PI) as described previously [29].
Brieﬂy, the cells were treated with various concentrations (0.25–
1 lM) of DHA for 48 h. After treatment, the cells were prepared
as a single cell suspension in 50 ll PBS, which was ﬁxed with
70% ethanol. The ﬁxed cells were harvested, resuspended in
500 ll PBS supplemented with 0.1% Triton X-100 and RNase A
(100 mg/ml), incubated at 37 C for 30 min, and stained with
50 mg/ml PI in the dark at 4 C for 30 min. The red ﬂuorescence
of individual cells was measured with a FACS Calibur ﬂow cytom-
eter (Becton Dickinson, Lincoln Park, NJ, USA). A minimum of
30000 events was collected per sample. The relative DNA content
per cell was obtained by measuring the ﬂuorescence of the PI that
bound stoichiometrically to DNA.
To determine ROS generation within DHA-treated cells, FACS
analysis was performed. Cells were exposed to a range concentra-
tions of DHA for 48 h, stained with 5 lg/ml DCFH-DA for 20 min,
subjected to ﬂow cytometry, and analysed by Cell Quest software
(Becton-Dickinson, San Jose, CA).
2.7. Atomic absorption spectrophotometric analyses
Cells were harvested by centrifugation (300 g, 5 min), washed
three times with PBS, and then dried at 50 C for 24 h. The dried
cells were digested with 5 ml of 14 M nitric and 10 M perchloric
acids (2:1, v/v) in a glass tube at 250 C for 8 h. The iron contents
of cell samples were determined by graphite furnace atomic
absorption spectrophotometry (Thermo Electron, USA). A standard
curve for iron was prepared from commercially available standards
(Spectrosol; BDH). Appropriate quality controls were included as
necessary.
2.8. RNA extraction and reverse transcriptase-PCR
Total RNA was isolated from the K562 cells utilizing Trizol
Reagent (Bio Basic) according to manufacturer’s instructions. After
cDNA was ampliﬁed, PCR was carried out with a Thermal cycler
(Eppendorf, Germany) as follows: 94 C for 5 min; 35 cycles at
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were separated on 1.5% agarose gel and visualized by ethidium
bromide staining. The expression intensities of optimized bands
were quantiﬁed with Quantity One software. Ampliﬁcation of glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the
internal control. TfR primers: forward, 50-CTGCCTCTTTCCTGTT
GTTGT-30 and reverse, 50-CTTTGGCCAAAATTTGGCAGC-30 (429bp).
2.9. Western blotting
Total protein extracts from cells were obtained by lysing K562
cells that were pretreated with DHA for 483 h in cold RIPA buffer
(50 mM Tris–HCl (PH8.0), 150 mM NaCl, 0.1% SDS, 1% sodium
deoxycholate, 1% Triton-X100, and 1 mM EDTA, supplemented
with 1 mM PMSF and 10 lg/ml Leupeptin) and incubated on ice
for 30 min. The protein concentration was determined using the
bicinchoninic acid assay (Bio-Rad). Subsequently, equal amounts
of protein were separated by 12% SDS-PAGE and transferred onto
a polyvinylidene diﬂuoride membrane. The membranes were
blocked with 5% non-fat milk and incubated overnight with the
primary antibodies at 4 C in PBS-T. The primary antibodies wereFig. 1. DHA induced autophagy. Control group: K562 cells were incubated in RPMI1640
for 48 h. DHA + TF group: K562 cells were incubated with 20 nM holotransferrin (TF) fo
incubated with 20 nM holotransferrin (TF) for 48 h. DHA induced autophagy was ana
proteins LC3-I and LC3-II were detected by Western blotting. The 2 lm upon the scale
which contained mitochondria.mouse anti-TfR (3B8 2A1), rabbit anti-Caspase-3 (H-277), rabbit
anti-LC3 monoclonal antibody, rabbit anti-Beclin 1 polyclonal
antibody, and goat anti-actin polyclonal antibody (I-19). Immuno-
reactivity was visualized with horseradish peroxidase-linked
secondary antibodies and chemiluminescence; b-actin levels were
analysed as controls for protein loading.
2.10. Data analysis
The statistical signiﬁcance of mean values was determined by
an unpaired two-tailed Student’s t-test. The signiﬁcance of the
dose–response curve was determined by an ANOVA. A P-value
<0.05 was considered to be statistically signiﬁcant.
3. Results
3.1. Induction of autophagy in K562 cells
Electron microscopy experiments showed that after treating
K562 cells with DHA, either with or without TF, a different mor-
phology was observed with numerous double-walled membrane-standard medium for 48 h. DHA group: K562 cells were incubated with 10 lM DHA
r 1 h and subsequently exposed to 10 lM DHA for 48 h. TF group: K562 cells were
lysed by transmission electron microscopy (3700), and the autophagy pathway
bar stands for magnifying 3700 folds. Black arrows referred to the autophagosome
Fig. 2. Effect of autophagy blocker 3-MA. 3-MA group: K562 cells were incubated
with 4 mM 3-MA. Effect of autophagy blocker 3-MA was analysed by transmission
electron microscopy, and the autophagy pathway proteins LC3-I and LC3-II were
detected by Western blotting. The autophagy blocker 3-MA was used to deﬁne the
functional relevance of the induction of autophagy in the overall toxicity of
DHA + holotransferrin. The 2 lm upon the scale bar stands for magnifying 3700
folds.
Fig. 3. Effect of DHA on intracellular ROS generation. (A) ROS generation within
DHA-treated cells was determined by FACS analysis. Numbers indicate the median
ﬂuorescence intensity values. Control group: K562 cells were incubated in
RPMI1640 standard medium for 48 h. DHA group: K562 cells were incubated with
10 lM DHA for 48 h. DHA + TF group: K562 cells were incubated with 20 nM
holotransferrin (TF) for 1 h and subsequently exposed to 10 lM DHA for 48 h. TF
group: K562 cells were incubated with 20 nM holotransferrin (TF) for 48 h. (B)
Estimating the number of TfR surface antigenic sites in K562. Cells are expressed as
arbitrary units of ﬂuorescence. ⁄P < 0.05; ⁄⁄P < 0.01, compared with control group,
#P < 0.05 compared to 10 lM DHA.
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intracellular organelles, primarily mitochondria, than untreated
cells (Fig. 1). Autophagy is also associated with the expression of
autophagic proteins. Therefore, we evaluated the effect of DHA
on the expression of LC3-I and LC3-II proteins, which are related
to the autophagic process in K562 cells. LC3-II is localized in the
autophagosome and has been used as an autophagosome marker.
LC3-I is formed by the proteolytic cleavage of cytosolic microtu-
bule-associated protein 1 light chain 3 (LC3) and eventually conju-
gates with phosphatidyl ethanolamine to form LC3-II. After K562
cells are treated with DHA under different conditions with iron,
we found that 10 lM DHA exerted a more powerful stimulation
of LC3-II protein expression (Fig. 1) when compared to K562 cells
with normal iron levels. Furthermore, we used the autophagy
blocker (3-methyladenine, 3-MA) to deﬁne the functional rele-
vance of the induction of autophagy in the overall toxicity of
DHA + holotransferrin. We found that when K562 cells were trea-
ted with 2 mM 3-MA, the expression of LC3-II protein was similar
to the control group. When K562 cells were treated with 4 mM 3-
MA, the expression of LC3-II protein was strikingly decreased.
More, in the transmission electron microscopy analysis on K562
cells treated with 4 mM 3-MA, it showed little double-walled
membrane-enclosed cytoplasmic vacuoles (Fig. 2). These results
indicate that DHA-induced autophagy may contribute to cell death
in K562 cells, not simply a non-functional consequence of the over-
all stress response.
Besides, in Fig. 2, it showed that 10 lMDHA could stimulate the
expression LC3-II protein, and the effect of 20 lM DHA on LC3-II
protein stimulation was even more severe. Though 10 nM holo-
transferrin had little effect on LC3-II protein stimulation, 20 nM
holotransferrin could stimulate the expression LC3-II protein. In
Fig. 1, the combination of 10 lM DHA and 20 nM holotransferrin
exerted a more powerful stimulation of LC3-II protein expression.
3.2. Up-regulation of intracellular ROS levels in K562 cells
After clearly establishing the ability of DHA to induce autoph-
agy in K562 cells, we assessed its effect on intracellular ROSproduction using ﬂuorescent ﬂow cytometry analysis (Fig. 3). The
exposure of cells to DHA resulted in a signiﬁcant increase in intra-
cellular ROS production. Moreover, after pretreatment of the K562
cells with 20 nM holotransferrin, an iron-loaded transferrin (plas-
ma iron carrying protein), the intracellular ROS level was higher
than that observed in the DHA group (P < 0.05).
3.3. Caspase cascade in DHA-induced apoptosis
We also studied the activation of caspase-3 and PARP by DHA in
iron-overloaded K562 cells. All groups expressed pro-caspase-3
(inactive form, a 32 kD band) as observed by Western blot analysis.
However, the cleaved form of caspase-3 (active), a 17 kD band,
could only be detected in the 10 lM DHA group both with and
without 20 nM holotransferrin. Meanwhile, the expression of
poly(ADP-ribose) polymerases (PARP, 112 kD) was also observed
to be down-regulated by 10 lMDHA with a corresponding up-reg-
ulation of cleaved PARP (active form, 85 kD) (Fig. 4). In addition,
cells pretreated with 20 nM holotransferrin 1 h prior to the admin-
istration of 10 lM DHA showed signiﬁcant up-regulation of
cleaved PARP in K562 cells when compared to iron-normal cells
Fig. 5. Effect of DHA on iron content in iron-normal and iron-overload K562 cells.
K562 cells were either incubated with 20 nM holotransferrin for 1 h and subse-
quently exposed to 2.5, 5, or 10 lMDHA or only exposed to 2.5, 5, or 10 lMDHA for
48 h. TF group: K562 cells were incubated with 20 nM holotransferrin (TF) for 48 h.
The quantitative iron content was determined with an atomic absorption spectro-
photometer. ⁄P < 0.05; ⁄⁄P < 0.01, compared with control group, #P < 0.05 compared
to 10 lM DHA.
Fig. 6. Effect of DHA on expression of TfR mRNA and protein. K562 cells were
incubated with 20 nM holotransferrin for 1 h and subsequently exposed to 10 lM
DHA for 48 h or only exposed to 10 lM DHA for 48 h. The GAPDH and beta-actin
were used as controls. The levels of TfR mRNA (A) and protein (B) were detected.
⁄P < 0.05; ⁄⁄P < 0.01; ⁄⁄⁄P < 0.001, compared with control group, #P < 0.05; ##P < 0.01
compared to 10 lM DHA.
Fig. 4. Cleavage of caspase-3 and PARP. Control group: K562 cells were incubated in
RPMI1640 standard medium for 48 h. DHA group: K562 cells were incubated with
10 lM DHA for 48 h. DHA + TF group: K562 cells were incubated with 20 nM
holotransferrin (TF) for 1 h and subsequently exposed to 10 lM DHA for 48 h. TF
group: K562 cells were incubated with 20 nM holotransferrin (TF) for 48 h.
Caspase-3, PARP and beta-actin expressions were analysed by Western blot.
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that caspase-3 and PARP were activated in apoptotic K562 cells
during treatment with DHA, especially when overloaded with iron.
3.4. Decrease of iron content in K562 cells
When the intracellular iron contents of K562 cells were mea-
sured by atomic absorption spectrometry, we found that the iron
content of iron-normal K562 cells was diminished by DHA in a
dose-dependent manner (Fig. 5). However, after pretreatment of
K562 cells with 20 nM holotransferrin, DHA exerted a more potent
effect than that observed under iron-normal conditions. Speciﬁ-
cally, the iron content of iron-overloaded K562 cells decreased
27.7 ± 2.0% (P < 0.05) with 10 lM DHA when compared with the
iron-normal group. These results suggest that the decrease in cel-
lular iron content is partially caused by the consumption of iron
through its reaction with DHA.
3.5. Down-regulation of TfR expression in K562 cells
TfR expression is controlled by the amount of iron that is re-
quired by the cell to maintain its metabolism. Therefore, tumor
cells in a state of high proliferation possess a higher density of
transferrin receptors [25]. We speciﬁcally raised the iron concen-
tration in the cell cultures with holotransferrin. The results ofWestern blot analysis and RT-PCR assay (Fig. 6) show that 10 lM
DHA inhibited the expression of TfR mRNA and TfR protein to a
greater extent under iron-overload conditions than under iron-
normal conditions in K562 cells (P < 0.05). These results indicate
that DHA may have a direct effect on TfR expression and that the
effect is further enhanced by iron. However, the mechanism still
needs more deﬁnitive study. Based on these results, it seems that
TfR expression in K562 is regulated at both the protein and post-
transcriptional level.
In addition, to determine if DHA interferes with the TfR surface
expression, we observed the expression of TfR in the cell using ﬂow
cytometry (Fig. 7). The number of TfR positive cells and the ﬂuores-
cence intensity (FI) reﬂect the intensity of the TfR surface expres-
sion. As shown in Fig. 7, K562 cells pretreated with 20 nM
holotransferrin 1 h prior to the administration of 10 lM DHA
showed a signiﬁcant reduction in the ﬂuorescence intensity levels
of TfR. The levels decreased by 30.2 ± 0.5% (P < 0.05) when com-
pared with iron-normal cells that were treated with DHA at the
same concentration. This is further supported by the results shown
above. According to the results of atomic absorption spectrophoto-
metric analyses and ﬂow cytometry analysis, the decrease of
transferrin receptor might be related to the consumption of iron
through its reaction with DHA. In this study, we found that the iron
content in TfR high expression K562 cells was diminished by DHA
in a dose-dependent manner. ‘‘Iron is important for mitochondrial
Fig. 7. Effect of DHA on TfR content. Flow cytometry analysis was performed after K562 cells were stained with monoclonal antibodies (closed histograms) against TfR and
with control isotype (open histograms). Numbers indicate the median ﬂuorescence intensity values. (A) Control group: K562 cells were incubated in RPMI1640 standard
medium for 48 h. DHA group: K562 cells were incubated with 10 lM DHA for 48 h. DHA + TF group: K562 cells were incubated with 20 nM holotransferrin (TF) for 1 h and
subsequently exposed to 10 lM DHA for 48 h. TF group: K562 cells were incubated with 20 nM holotransferrin (TF) for 48 h. (B) Estimating the number of TfR surface
antigenic sites in K562. Cells are expressed as arbitrary units of ﬂuorescence. ⁄P < 0.05; ⁄⁄P < 0.01, compared with control group, #P < 0.01 compared to 10 lM DHA.
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tion will also affect basic mitochondrial metabolism and function.
Furthermore, the expression of TfR was inﬂuenced by the iron sta-
tus [30].
3.6. Enhancement of the cytotoxicity of DHA toward iron-overloaded
K562 cells
The cytotoxic activities of DHA in K562 cells were assessed by
examining its effects on cellular dehydrogenase activity with an
MTT assay. The results revealed that DHA reduced cell survival in
a dose-dependent manner. The K562 cell lines showed low IC50
values (11.33 lM), and the 95% conﬁdence interval was 9.38–
13.68 lM (Fig. 8B).Since DHA becomes more cytotoxic in the presence of ferrous
iron, we investigated the effect of holotransferrin on the prolifera-
tion of K562 cells. The result shows that holotransferrin maximally
promoted cell growth at a concentration of approximately 20 nM,
but the effect was not dose-dependent (Fig. 8A).
We subsequently examined the effect of holotransferrin on the
sensitization of K562 cells to DHA. As shown in Fig. 8B, cells pre-
treated with 20 nM holotransferrin 1 h prior to administration of
DHA showed a signiﬁcantly reduced level of cell survival when
compared to cells that were not treated with holotransferrin. The
iron-overloaded K562 cell lines showed even lower IC50 values
(3.67 lM), and the 95% conﬁdence interval was 3.20–4.21 lM.
The combination of holotransferrin and DHA resulted in 3.1-fold
increase in cytotoxicity when compared with the result from
Fig. 8. Effect of DHA on proliferation of iron-normal and iron-overload K562 cells.
(A) K562 cells were seeded into 96-well plates and incubated with holotransferrin
at various concentrations for 48 h. (B) Open circle – K562 cells were seeded into 96-
well plates and incubated for 48 h with DHA at various concentrations; solid circle –
K562 cells were seeded into 96-well plates and incubated with 20 nM holotrans-
ferrin for 1 h, then various concentrations of DHA were added and incubation was
continued for 48 h. Subsequently, the growth inhibition effect of DHA on K562 cells
was determined by modiﬁed microculture tetrazolium (MTT) assay.
Table 1
Anti-tumor activity of DHA alone and in combination with holotransferrin in K562
and HL60 cells.
Cell line DHA IC50 (lm) DHA + TF IC50 (lm) Degree of modulation
K562 11.33 3.67 3.1
HL60 1.74 0.91 1.9
DHA IC50 (lM): K562 cells and HL60 cells were seeded into 96-well plates and
incubated for 48 h with DHA at various concentrations. DHA + TF IC50 (lM): K562
cells were seeded into 96-well plates and incubated with 20 nM holotransferrin for
1 h, then various concentrations of DHA were added and incubation was continued
for 48 h. Subsequently, the growth inhibition effect of DHA on K562 cells was
determined by modiﬁed microculture tetrazolium (MTT) assay.
Degree of modulation = DHA IC50 (lM)/(DHA + TF)IC50 (lM).
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was also observed in HL60 cells when DHA was administered with
or without holotransferrin (Table 1), but the degree of modulation
of the IC50 is lower than that in K562 cells that were administered
DHA with or without holotransferrin.
3.7. Growth of K562 cells in iron-normal and iron-overloaded
conditions arrested by DHA
To provide more direct evidence for the effect of DHA-induced
cytotoxicity in K562 cells, we raised the iron concentration in the
cell cultures with holotransferrin. The K562 cells were incubated
with 20 nM holotransferrin for 1 h, and then the cells were treated
with DHA for 48 h. Fig. 9 shows the comparison of morphological
apoptotic alterations after 48 h of treatment with DHA between
the early and late apoptotic cells as shown by their membrane
integrities. The normal morphologies of the cells are shown in
Fig. 9A.When treatedwith 2.5–10 lMDHA for 48 h, the cells exhib-
ited cell shrinkage, membrane blebbing, chromatin condensation,
and the formation of apoptotic bodies (Fig. 9B–D). All of these are
characteristic morphological changes associated with apoptosis.
Therefore, these morphological changes suggest that apoptosis
occurs in iron-overloaded K562 cells after treatment with DHA.
Furthermore, we investigated the effects of DHA on the cell
growth cycle of K562 cells by ﬂow cytometry analysis (Fig. 10).K562 cells exposed to 10 lM DHA in an iron-overloaded condition
(Fig. 10, DHA + TF) showed a signiﬁcant decrease of cells in the S
phase (53.82%) and a corresponding increase of cells in the G2/M
phase (100.06%) and the sub-G1 phase (610.29%) when compared
to the control group. When K562 cells were exposed to 10 lM
DHA in an iron-normal condition (Fig. 10, DHA), the decrease of
cells in the S phase was just 17.55%, and the increase of G2/M phase
and sub-G1 phase was 62.37% and 237.45% when compared to the
control group. Compared to K562 cells in iron-normal conditions,
DHA more effectively induced the arrest of iron-overloaded K562
cell growth in the G2/M phase and partially arrested in the apopto-
tic sub-G1 phase. These results were directly correlated with the
inhibition of cell proliferation.
4. Discussion
In our previous study [31], we found that DHA-mediated apop-
tosis in HL60 cells was associated with the down-regulation of TfR
expression, reduction of iron uptake, and regulation of the mito-
chondrial pathway protein. In the present study, we further inves-
tigated the anti-proliferation and ROS toxicity induced by DHA and
its possible mechanism in myeloid leukemia K562 cells when pre-
treated with holotransferrin. We found that DHA inhibited the
growth of K562 cells more effectively when the iron concentration
was raised. The mechanism may be related to the autophagic effect
induced by ROS toxicity, which includes the activation of caspases,
down-regulation of TfR expression, reduction in iron uptake, and
arrest of the cell cycle by DHA.
Autophagy, which is designated as type II programmed cell
death, has also been reported to be an anticancer mechanism of
ROS, which results in the inhibition of the growth of a variety of
malignant cells, such as chronic myeloid leukemia cells, malignant
glioma cells, and esophageal cancer cells. In this report, we demon-
strate an increase in the autophagic ﬂux in K562 cells that are trea-
ted with DHA. This could be partially caused by the toxicity of ROS
that are generated by DHA. In addition, DHA-induced autophagy
was monitored by measuring LC3-I and LC3-II protein expression.
LC3-I (18 kDa) is cleaved to produce LC3-II (16 kDa), which is local-
ized exclusively in autophagosomal membranes [32]. These results
showed that DHA increased LC3-II protein expression. When
compared to iron-normal K562 cells, 10 lM DHA showed a more
powerful stimulation of expression of LC3-II protein under iron-
overloaded conditions. In order to deﬁne the effect of functional
relevance of the induction of autophagy, we treated K562 cells
with the autophagy blocker (3-methyladenine, 3-MA). According
to the results, we suggest that DHA activates the autophagic
pathway.
It has been reported that DHA displays cytotoxic activity in ac-
tively proliferating mammalian cells [2], and it has also been sug-
gested that this toxicity is related to a high intracellular iron
concentration and the generation of ROS [3]. When formed intra-
cellularly, ROS can cause macromolecular damage followed by cell
Fig. 9. Morphological analysis performed with ﬂuorescence microscopy. K562 cells were incubated with 20 nM holotransferrin for 1 h, then treated with DHA or without for
48 h. The cells were stained by AO/EB, and the morphology was immediately assessed using ﬂuorescence microscopy. (A) Control cells with bright green nuclei and intact
structure; (B) DHA 2.5 lM; (C) DHA 5 lM; (D) DHA 10 lM. White arrows mark the early apoptotic cells with bright green nuclei as dense green areas in the nucleus. Red
arrows mark late apoptotic cells with an orange nucleus showing the condensation of chromatin as dense orange areas and reduced cell size.
110 Z. Wang et al. / FEBS Open Bio 2 (2012) 103–112death. In several settings, autophagic signaling initiates apoptosis,
but under other conditions, inhibition of autophagy triggers an
apoptotic cell death program [33,34]. Our data show that DHA sig-
niﬁcantly increased intracellular ROS production. Moreover, after
pretreatment of K562 cells with 20 nM holotransferrin, the intra-
cellular ROS level was much higher than that observed with the
DHA group (P < 0.05). This suggests that the regulation of the intra-
cellular ROS level by DHA might be related to DHA-induced
autophagy, its detail effect needed our further investigation.
Accumulating data indicate that there is a link between apopto-
sis and autophagy. In some systems, the induction of autophagy
has been shown to contribute to or enhance the apoptotic re-
sponse. When treated with 2.5–10 lM DHA for 48 h, K562 cells
that were pretreated with holotransferrin exhibited cell shrinkage,
membrane blebbing, chromatin condensation, and the formation
of apoptotic bodies, which suggests the occurrence of apoptosis
in iron-overloaded K562 cells after treatment with DHA. In most
cases, the activation of the caspase cascade accompanies apoptosis.
Of the several different members of caspases identiﬁed in mamma-
lian cells, caspase-3 plays a direct role in the proteolytic cleavage of
cellular proteins that are responsible for the progression to apopto-
sis. The observation of DHA-mediated activation of pro-caspase-3
and the subsequent cleavage of its substrate PARP suggest that
the mitochondrial pathway plays an important role in DHA-in-
duced apoptosis, and the effect of DHA was more signiﬁcant under
conditions of iron overload. The results of cell cycle analysis in our
study also demonstrate that the DHA-induced arrest of K562 cell
growth in the G2/M phase, and partially in the apoptotic sub-G1
phase, is directly correlated with the inhibition of cell proliferation,
which may also relate to iron levels and ROS toxicity.
Because iron is required for the drug-induced formation of ROS,
the activation of caspases, and consequent apoptosis, the intracellu-
lar iron content of K562 cells was measured by atomic absorptionspectrometry. We found that the iron content in iron-normal
K562 cells was decreased by DHA in a dose-dependent manner. It
has been reported that iron(II)–glycine sulfate (Ferrosanol) and
transferrin have increased the cytotoxicity of free artesunate,
artesunate microencapsulated in maltosyl-h-cyclodextrin, and
artemisinin toward CCRF-CEM leukemia and U373 astrocytoma
cells 1.5- to 10.3-fold when compared with that result from artem-
isinins applied without iron [35]. Therefore, to provide more direct
evidence for the effect of DHA-induced cytotoxicity in K562 cells,
we raised the iron concentration in the cell cultures with holotrans-
ferrin. The iron content of iron-overloaded K562 cells was de-
creased 27.7 ± 2.0% (P < 0.05) by 10 lM DHA when compared to
the results from the iron-normal group.
Because TfR expression is controlled by the amount of iron re-
quired to maintain the metabolism of the cell, tumor cells in a state
of high proliferation have a high density of transferrin receptors
[36]. Therefore, we examined whether DHA could interfere with
TfR expression, which would imply an effect on the proliferation
of cancer cells. The results showed that 10 lM DHA inhibited the
expression of TfR mRNA and protein in iron-overloaded conditions
to a greater extent than in iron-normal K562 cells (P < 0.05). This is
further supported by the results from ﬂow cytometry analysis.
According to the results of atomic absorption spectrophotometric
analyses and ﬂow cytometry analysis, the decrease in cellular iron
content is not only partially linked to the decrease in transferrin
receptor expression, but also partially caused by the consumption
of iron through its reaction with DHA. DHA inhibited the prolifer-
ation of iron-normal K562 cells in a dose- and time-dependent
manner, and the IC50 was 11.33 lM. Moreover, DHA suppressed
the proliferation of iron-overloaded K562 cells to a greater extent,
and the IC50 was 3.67 lM, which represents a 3.1-fold increase in
the cytotoxicity of DHA when compared to the result from iron-
normal cells. This result is consistent with the data published by
Fig. 10. Flow cytometric analysis of propidium iodide-stained and iron-overloaded K562 cells. The growth of K562 cells arrested by dihydroartemisinin (DHA). Control group:
K562 cells were incubated in RPMI1640 standard medium for 48 h. DHA group: K562 cells were incubated with 10 lM DHA for 48 h. DHA + TF group: K562 cells were
incubated with 20 nM holotransferrin (TF) for 1 h and subsequently exposed to 10 lMDHA for 48 h. The cells were next stained with propidium iodide (PI), and the cell cycle
proﬁles were determined by ﬂow cytometry. Cells in sub-G1, G0/G1, S, and G2/M phases of the cell cycle fractions are expressed as percentages of the total cell population. The
graph is representative of three separate experiments.
Z. Wang et al. / FEBS Open Bio 2 (2012) 103–112 111Lai et al. [7] and Efferth et al. [4]. However, in our previous re-
search, we found that treatment with holotransferrin made little
difference in the effect of DHA on HL60 cells. In addition, a recent
report on 36 human tumor cell lines showed that an increase in the
cytotoxicity of another artemisinin derivative, artesunate, was ob-
served in only two-thirds of the cell lines, and the addition of iron
did not enhance the cytotoxicity of artesunate in the other cell
lines [37]. This may indicate that the iron dependency of dihyd-
roartemisinin-mediated cytotoxicity may differ from one cell line
to another, and further investigations are still needed.
In summary, DHA induces autophagy and inhibits the growth of
iron-loaded human myeloid leukemia K562 cells via ROS toxicity,
which includes the down-regulation of TfR expression and induc-
tion of apoptosis through the mitochondrial pathway. However,
we suggest that the mechanism of inhibition by DHA on K562 cell
proliferation in vitro is still not clear, and further studies are
needed to gain a full understanding of the in vivo effects.
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